Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonism: This component acts synergistically with GLP-1
Cheng, Q
When that pathway is disrupted by obesity, aging, or poor diet GLP-1 production downstream suffers
The AP densely co-expresses the GIPR and the GLP-1R, enabling it to directly receive and integrate dual hormonal signals from the systemic circulation
Programs that can offer both, along with oral and injectable formats, give patients more room to find what actually works for their body
Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial